WIRKSTOFFKOMBINATION ZUR BEHANDLUNG REIFER HAUT II
    14.
    发明公开
    WIRKSTOFFKOMBINATION ZUR BEHANDLUNG REIFER HAUT II 审中-公开
    活性物质,用于治疗性皮肤II组合

    公开(公告)号:EP2451434A2

    公开(公告)日:2012-05-16

    申请号:EP08875470.0

    申请日:2008-12-17

    摘要: The invention relates to topical cosmetic or dermatological compositions for the treatment of mature or intrinsically or extrinsically aged skin, in particular for anti-wrinkle treatment. Said compositions contain a combination of at least one soy protein hydrolysate with an average molecular weight ranging between 600 and 1,000 dalton, preferably 800 dalton, at least one hydrophilic extract of abelmusk seed, at least one active ingredient selected from hyaluronic acid, silanol ethers, silanol esters and hyaluronic acid salts, and at least one dipeptide, tripeptide, tetrapeptide, pentapeptide or hexapeptide, that can be N-acylated and/or esterified and/or be present as a physiologically acceptable salt and that can stimulate the release of growth factors such as TGF-β and subsequently stimulate collagen and/or fibronectin synthesis in the skin.

    KOSMETISCHE ZUSAMMENSETZUNGEN ZUR HAUTAUFHELLUNG

    公开(公告)号:EP3344226A1

    公开(公告)日:2018-07-11

    申请号:EP16760031.1

    申请日:2016-08-29

    摘要: Cosmetic or dermatological composition, which contain - depending on the total weight thereof - a) 0.001 to 15.00 wt.% ascorbic acid, an ascorbic acid salt and/or an ascorbic acid derivative, and b) 0.100 to 5.00 wt.% of at least one compound of the following formula, HO-(C
    6 H
    4 )-O-CH(R)-C(O)OX, in which X stands for –H, an alk(en)yl group having 1 to 10 carbon atoms, for an alkali metal cation or for an ammonia ion, and R stands for –H or for a linear or cross-linked, saturated or unsaturated alkyl group having 1 to 20 carbon atoms, and which are suitable for the non-therapeutic, cosmetic use for treatment of the skin, in particular for reducing, removing and/or inhibiting irregular pigmentations (age spots and/or freckles) and/or obtaining a uniform skin appearance and/or preventing and/or inhibiting the formation of the pigments lipofuscin and melanin in the skin, affecting all relevant steps of melanogenesis, including inhibiting tyrosinase, inhibiting the TRP1 and TRP2 enzyme (preventing the conversion of tyrosine into melanin), inhibiting the gene gp100 (inhibiting melanin transfer via melanogenesis).